Core Scientific's Q4 revenue missed expectations, causing its shares to decline despite a large net income boost from non-cash holdings.SummarySubscribe to TodayOnChain membership to read full news summaries and browse without display ads.
Anchorage CEO says AI agents need bank accounts for ‘The Jetsons’-like future
Attackers drove 63% of early use of Ethereum’s new smart wallet feature
Bitcoin ETFs Post $606 Million Inflow, Biggest Since May 1
Gate First Launches Japanese Stock Trading, Expanding Its One-Stop Global Asset Trading Platform
Live updates: Bitcoin, ether ETFs pull in $800 million as inflows surge for a second day
Solana Aims to Cut Block Time in Half, and You Can Watch It Live
South Korea’s Shinhan partners with Solana Foundation, Etherfuse, Orca for tokenized fund issuance
Crypto Bears Burned as Short Liquidations Hit $1.06 Billion in a Day
MANTRA token plunges 18% to record low as blockchain halts after exploit
South Korean lawmakers seek expanded FIU powers over unregistered crypto firms
